Semi-Solid Dosage Form Market
1 Semi-Solid Dosage Form Market Overview
1.1 Product Overview and Scope of Semi-Solid Dosage Form
1.2 Semi-Solid Dosage Form Segment by Type
1.2.1 Global Semi-Solid Dosage Form Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Ointments
1.2.3 Gels
1.2.4 Others
1.3 Semi-Solid Dosage Form Segment by Application
1.3.1 Global Semi-Solid Dosage Form Sales Comparison by Application: (2022-2028)
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Global Semi-Solid Dosage Form Market Size Estimates and Forecasts
1.4.1 Global Semi-Solid Dosage Form Revenue 2017-2028
1.4.2 Global Semi-Solid Dosage Form Sales 2017-2028
1.4.3 Semi-Solid Dosage Form Market Size by Region: 2017 Versus 2021 Versus 2028
2 Semi-Solid Dosage Form Market Competition by Manufacturers
2.1 Global Semi-Solid Dosage Form Sales Market Share by Manufacturers (2017-2022)
2.2 Global Semi-Solid Dosage Form Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Semi-Solid Dosage Form Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Semi-Solid Dosage Form Manufacturing Sites, Area Served, Product Type
2.5 Semi-Solid Dosage Form Market Competitive Situation and Trends
2.5.1 Semi-Solid Dosage Form Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Semi-Solid Dosage Form Players Market Share by Revenue
2.5.3 Global Semi-Solid Dosage Form Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Semi-Solid Dosage Form Retrospective Market Scenario by Region
3.1 Global Semi-Solid Dosage Form Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Semi-Solid Dosage Form Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Semi-Solid Dosage Form Market Facts & Figures by Country
3.3.1 North America Semi-Solid Dosage Form Sales by Country
3.3.2 North America Semi-Solid Dosage Form Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Semi-Solid Dosage Form Market Facts & Figures by Country
3.4.1 Europe Semi-Solid Dosage Form Sales by Country
3.4.2 Europe Semi-Solid Dosage Form Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Semi-Solid Dosage Form Market Facts & Figures by Region
3.5.1 Asia Pacific Semi-Solid Dosage Form Sales by Region
3.5.2 Asia Pacific Semi-Solid Dosage Form Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Semi-Solid Dosage Form Market Facts & Figures by Country
3.6.1 Latin America Semi-Solid Dosage Form Sales by Country
3.6.2 Latin America Semi-Solid Dosage Form Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Semi-Solid Dosage Form Market Facts & Figures by Country
3.7.1 Middle East and Africa Semi-Solid Dosage Form Sales by Country
3.7.2 Middle East and Africa Semi-Solid Dosage Form Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Semi-Solid Dosage Form Historic Market Analysis by Type
4.1 Global Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)
4.2 Global Semi-Solid Dosage Form Revenue Market Share by Type (2017-2022)
4.3 Global Semi-Solid Dosage Form Price by Type (2017-2022)
5 Global Semi-Solid Dosage Form Historic Market Analysis by Application
5.1 Global Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)
5.2 Global Semi-Solid Dosage Form Revenue Market Share by Application (2017-2022)
5.3 Global Semi-Solid Dosage Form Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Johnson & Johnson Semi-Solid Dosage Form Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Corporation Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merck & Co Semi-Solid Dosage Form Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer AG Semi-Solid Dosage Form Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Hisamitsu Pharmaceutical
6.4.1 Hisamitsu Pharmaceutical Corporation Information
6.4.2 Hisamitsu Pharmaceutical Description and Business Overview
6.4.3 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product Portfolio
6.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Corporation Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Glenmark Pharmaceuticals Semi-Solid Dosage Form Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Cipla Ltd
6.6.1 Cipla Ltd Corporation Information
6.6.2 Cipla Ltd Description and Business Overview
6.6.3 Cipla Ltd Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Cipla Ltd Semi-Solid Dosage Form Product Portfolio
6.6.5 Cipla Ltd Recent Developments/Updates
6.7 Nestl? SA
6.6.1 Nestl? SA Corporation Information
6.6.2 Nestl? SA Description and Business Overview
6.6.3 Nestl? SA Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Nestl? SA Semi-Solid Dosage Form Product Portfolio
6.7.5 Nestl? SA Recent Developments/Updates
6.8 Novartis AG
6.8.1 Novartis AG Corporation Information
6.8.2 Novartis AG Description and Business Overview
6.8.3 Novartis AG Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Novartis AG Semi-Solid Dosage Form Product Portfolio
6.8.5 Novartis AG Recent Developments/Updates
6.9 GlaxoSmithKline plc
6.9.1 GlaxoSmithKline plc Corporation Information
6.9.2 GlaxoSmithKline plc Description and Business Overview
6.9.3 GlaxoSmithKline plc Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.9.4 GlaxoSmithKline plc Semi-Solid Dosage Form Product Portfolio
6.9.5 GlaxoSmithKline plc Recent Developments/Updates
6.10 Bausch Health Companies
6.10.1 Bausch Health Companies Corporation Information
6.10.2 Bausch Health Companies Description and Business Overview
6.10.3 Bausch Health Companies Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Bausch Health Companies Semi-Solid Dosage Form Product Portfolio
6.10.5 Bausch Health Companies Recent Developments/Updates
6.11 Allergan plc
6.11.1 Allergan plc Corporation Information
6.11.2 Allergan plc Semi-Solid Dosage Form Description and Business Overview
6.11.3 Allergan plc Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Allergan plc Semi-Solid Dosage Form Product Portfolio
6.11.5 Allergan plc Recent Developments/Updates
6.12 Biofrontera, Inc.
6.12.1 Biofrontera, Inc. Corporation Information
6.12.2 Biofrontera, Inc. Semi-Solid Dosage Form Description and Business Overview
6.12.3 Biofrontera, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Biofrontera, Inc. Semi-Solid Dosage Form Product Portfolio
6.12.5 Biofrontera, Inc. Recent Developments/Updates
6.13 Crown Laboratories Inc.
6.13.1 Crown Laboratories Inc. Corporation Information
6.13.2 Crown Laboratories Inc. Semi-Solid Dosage Form Description and Business Overview
6.13.3 Crown Laboratories Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Crown Laboratories Inc. Semi-Solid Dosage Form Product Portfolio
6.13.5 Crown Laboratories Inc. Recent Developments/Updates
6.14 Akorn Inc. (US)
6.14.1 Akorn Inc. (US) Corporation Information
6.14.2 Akorn Inc. (US) Semi-Solid Dosage Form Description and Business Overview
6.14.3 Akorn Inc. (US) Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Akorn Inc. (US) Semi-Solid Dosage Form Product Portfolio
6.14.5 Akorn Inc. (US) Recent Developments/Updates
6.15 Ingenus Pharmaceuticals
6.15.1 Ingenus Pharmaceuticals Corporation Information
6.15.2 Ingenus Pharmaceuticals Semi-Solid Dosage Form Description and Business Overview
6.15.3 Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Ingenus Pharmaceuticals Semi-Solid Dosage Form Product Portfolio
6.15.5 Ingenus Pharmaceuticals Recent Developments/Updates
6.16 Sun Pharmaceuticals
6.16.1 Sun Pharmaceuticals Corporation Information
6.16.2 Sun Pharmaceuticals Semi-Solid Dosage Form Description and Business Overview
6.16.3 Sun Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Sun Pharmaceuticals Semi-Solid Dosage Form Product Portfolio
6.16.5 Sun Pharmaceuticals Recent Developments/Updates
6.17 Crescita Therapeutics Inc.
6.17.1 Crescita Therapeutics Inc. Corporation Information
6.17.2 Crescita Therapeutics Inc. Semi-Solid Dosage Form Description and Business Overview
6.17.3 Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Crescita Therapeutics Inc. Semi-Solid Dosage Form Product Portfolio
6.17.5 Crescita Therapeutics Inc. Recent Developments/Updates
6.18 Mylan N.V.
6.18.1 Mylan N.V. Corporation Information
6.18.2 Mylan N.V. Semi-Solid Dosage Form Description and Business Overview
6.18.3 Mylan N.V. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Mylan N.V. Semi-Solid Dosage Form Product Portfolio
6.18.5 Mylan N.V. Recent Developments/Updates
6.19 Encore Dermatology, Inc.
6.19.1 Encore Dermatology, Inc. Corporation Information
6.19.2 Encore Dermatology, Inc. Semi-Solid Dosage Form Description and Business Overview
6.19.3 Encore Dermatology, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Encore Dermatology, Inc. Semi-Solid Dosage Form Product Portfolio
6.19.5 Encore Dermatology, Inc. Recent Developments/Updates
6.20 LEO Pharma
6.20.1 LEO Pharma Corporation Information
6.20.2 LEO Pharma Semi-Solid Dosage Form Description and Business Overview
6.20.3 LEO Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.20.4 LEO Pharma Semi-Solid Dosage Form Product Portfolio
6.20.5 LEO Pharma Recent Developments/Updates
6.21 Almirall, S.A
6.21.1 Almirall, S.A Corporation Information
6.21.2 Almirall, S.A Semi-Solid Dosage Form Description and Business Overview
6.21.3 Almirall, S.A Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Almirall, S.A Semi-Solid Dosage Form Product Portfolio
6.21.5 Almirall, S.A Recent Developments/Updates
6.22 Aclaris Therapeutics, Inc.
6.22.1 Aclaris Therapeutics, Inc. Corporation Information
6.22.2 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Description and Business Overview
6.22.3 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product Portfolio
6.22.5 Aclaris Therapeutics, Inc. Recent Developments/Updates
6.23 Taro Pharmaceutical Industries Ltd.
6.23.1 Taro Pharmaceutical Industries Ltd. Corporation Information
6.23.2 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Description and Business Overview
6.23.3 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product Portfolio
6.23.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
6.24 Teligent Pharma
6.24.1 Teligent Pharma Corporation Information
6.24.2 Teligent Pharma Semi-Solid Dosage Form Description and Business Overview
6.24.3 Teligent Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Teligent Pharma Semi-Solid Dosage Form Product Portfolio
6.24.5 Teligent Pharma Recent Developments/Updates
6.25 Perrigo Pharma
6.25.1 Perrigo Pharma Corporation Information
6.25.2 Perrigo Pharma Semi-Solid Dosage Form Description and Business Overview
6.25.3 Perrigo Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Perrigo Pharma Semi-Solid Dosage Form Product Portfolio
6.25.5 Perrigo Pharma Recent Developments/Updates
7 Semi-Solid Dosage Form Manufacturing Cost Analysis
7.1 Semi-Solid Dosage Form Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Semi-Solid Dosage Form
7.4 Semi-Solid Dosage Form Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Semi-Solid Dosage Form Distributors List
8.3 Semi-Solid Dosage Form Customers
9 Semi-Solid Dosage Form Market Dynamics
9.1 Semi-Solid Dosage Form Industry Trends
9.2 Semi-Solid Dosage Form Market Drivers
9.3 Semi-Solid Dosage Form Market Challenges
9.4 Semi-Solid Dosage Form Market Restraints
10 Global Market Forecast
10.1 Semi-Solid Dosage Form Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Semi-Solid Dosage Form by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Semi-Solid Dosage Form by Type (2023-2028)
10.2 Semi-Solid Dosage Form Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Semi-Solid Dosage Form by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Semi-Solid Dosage Form by Application (2023-2028)
10.3 Semi-Solid Dosage Form Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Semi-Solid Dosage Form by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Semi-Solid Dosage Form by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Semi-Solid Dosage Form Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Semi-Solid Dosage Form Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Semi-Solid Dosage Form Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Semi-Solid Dosage Form Market Competitive Situation by Manufacturers in 2021
Table 5. Global Semi-Solid Dosage Form Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Semi-Solid Dosage Form Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Semi-Solid Dosage Form Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Semi-Solid Dosage Form Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Semi-Solid Dosage Form Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Semi-Solid Dosage Form Manufacturing Sites and Area Served
Table 11. Manufacturers Semi-Solid Dosage Form Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Semi-Solid Dosage Form by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Semi-Solid Dosage Form as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Semi-Solid Dosage Form Sales by Region (2017-2022) & (K Units)
Table 16. Global Semi-Solid Dosage Form Sales Market Share by Region (2017-2022)
Table 17. Global Semi-Solid Dosage Form Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Semi-Solid Dosage Form Revenue Market Share by Region (2017-2022)
Table 19. North America Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)
Table 20. North America Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)
Table 21. North America Semi-Solid Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)
Table 23. Europe Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)
Table 24. Europe Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)
Table 25. Europe Semi-Solid Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Semi-Solid Dosage Form Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Semi-Solid Dosage Form Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Semi-Solid Dosage Form Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Semi-Solid Dosage Form Revenue Market Share by Region (2017-2022)
Table 31. Latin America Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)
Table 33. Latin America Semi-Solid Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Semi-Solid Dosage Form Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)
Table 39. Global Semi-Solid Dosage Form Sales by Type (2017-2022) & (K Units)
Table 40. Global Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)
Table 41. Global Semi-Solid Dosage Form Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Semi-Solid Dosage Form Revenue Share by Type (2017-2022)
Table 43. Global Semi-Solid Dosage Form Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Semi-Solid Dosage Form Sales (K Units) by Application (2017-2022)
Table 45. Global Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)
Table 46. Global Semi-Solid Dosage Form Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Semi-Solid Dosage Form Revenue Share by Application (2017-2022)
Table 48. Global Semi-Solid Dosage Form Price by Application (2017-2022) & (US$/Unit)
Table 49. Johnson & Johnson Corporation Information
Table 50. Johnson & Johnson Description and Business Overview
Table 51. Johnson & Johnson Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Johnson & Johnson Semi-Solid Dosage Form Product
Table 53. Johnson & Johnson Recent Developments/Updates
Table 54. Merck & Co Corporation Information
Table 55. Merck & Co Description and Business Overview
Table 56. Merck & Co Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Merck & Co Semi-Solid Dosage Form Product
Table 58. Merck & Co Recent Developments/Updates
Table 59. Bayer AG Corporation Information
Table 60. Bayer AG Description and Business Overview
Table 61. Bayer AG Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Bayer AG Semi-Solid Dosage Form Product
Table 63. Bayer AG Recent Developments/Updates
Table 64. Hisamitsu Pharmaceutical Corporation Information
Table 65. Hisamitsu Pharmaceutical Description and Business Overview
Table 66. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product
Table 68. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 69. Glenmark Pharmaceuticals Corporation Information
Table 70. Glenmark Pharmaceuticals Description and Business Overview
Table 71. Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Glenmark Pharmaceuticals Semi-Solid Dosage Form Product
Table 73. Glenmark Pharmaceuticals Recent Developments/Updates
Table 74. Cipla Ltd Corporation Information
Table 75. Cipla Ltd Description and Business Overview
Table 76. Cipla Ltd Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Cipla Ltd Semi-Solid Dosage Form Product
Table 78. Cipla Ltd Recent Developments/Updates
Table 79. Nestl? SA Corporation Information
Table 80. Nestl? SA Description and Business Overview
Table 81. Nestl? SA Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Nestl? SA Semi-Solid Dosage Form Product
Table 83. Nestl? SA Recent Developments/Updates
Table 84. Novartis AG Corporation Information
Table 85. Novartis AG Description and Business Overview
Table 86. Novartis AG Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Novartis AG Semi-Solid Dosage Form Product
Table 88. Novartis AG Recent Developments/Updates
Table 89. GlaxoSmithKline plc Corporation Information
Table 90. GlaxoSmithKline plc Description and Business Overview
Table 91. GlaxoSmithKline plc Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. GlaxoSmithKline plc Semi-Solid Dosage Form Product
Table 93. GlaxoSmithKline plc Recent Developments/Updates
Table 94. Bausch Health Companies Corporation Information
Table 95. Bausch Health Companies Description and Business Overview
Table 96. Bausch Health Companies Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Bausch Health Companies Semi-Solid Dosage Form Product
Table 98. Bausch Health Companies Recent Developments/Updates
Table 99. Allergan plc Corporation Information
Table 100. Allergan plc Description and Business Overview
Table 101. Allergan plc Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Allergan plc Semi-Solid Dosage Form Product
Table 103. Allergan plc Recent Developments/Updates
Table 104. Biofrontera, Inc. Corporation Information
Table 105. Biofrontera, Inc. Description and Business Overview
Table 106. Biofrontera, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Biofrontera, Inc. Semi-Solid Dosage Form Product
Table 108. Biofrontera, Inc. Recent Developments/Updates
Table 109. Crown Laboratories Inc. Corporation Information
Table 110. Crown Laboratories Inc. Description and Business Overview
Table 111. Crown Laboratories Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Crown Laboratories Inc. Semi-Solid Dosage Form Product
Table 113. Crown Laboratories Inc. Recent Developments/Updates
Table 114. Akorn Inc. (US) Corporation Information
Table 115. Akorn Inc. (US) Description and Business Overview
Table 116. Akorn Inc. (US) Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Akorn Inc. (US) Semi-Solid Dosage Form Product
Table 118. Akorn Inc. (US) Recent Developments/Updates
Table 119. Ingenus Pharmaceuticals Corporation Information
Table 120. Ingenus Pharmaceuticals Description and Business Overview
Table 121. Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Ingenus Pharmaceuticals Semi-Solid Dosage Form Product
Table 123. Ingenus Pharmaceuticals Recent Developments/Updates
Table 124. Sun Pharmaceuticals Corporation Information
Table 125. Sun Pharmaceuticals Description and Business Overview
Table 126. Sun Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Sun Pharmaceuticals Semi-Solid Dosage Form Product
Table 128. Sun Pharmaceuticals Recent Developments/Updates
Table 129. Crescita Therapeutics Inc. Corporation Information
Table 130. Crescita Therapeutics Inc. Description and Business Overview
Table 131. Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Crescita Therapeutics Inc. Semi-Solid Dosage Form Product
Table 133. Crescita Therapeutics Inc. Recent Developments/Updates
Table 134. Mylan N.V. Corporation Information
Table 135. Mylan N.V. Description and Business Overview
Table 136. Mylan N.V. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Mylan N.V. Semi-Solid Dosage Form Product
Table 138. Mylan N.V. Recent Developments/Updates
Table 139. Encore Dermatology, Inc. Corporation Information
Table 140. Encore Dermatology, Inc. Description and Business Overview
Table 141. Encore Dermatology, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Encore Dermatology, Inc. Semi-Solid Dosage Form Product
Table 143. Encore Dermatology, Inc. Recent Developments/Updates
Table 144. LEO Pharma Corporation Information
Table 145. LEO Pharma Description and Business Overview
Table 146. LEO Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. LEO Pharma Semi-Solid Dosage Form Product
Table 148. LEO Pharma Recent Developments/Updates
Table 149. Almirall, S.A Corporation Information
Table 150. Almirall, S.A Description and Business Overview
Table 151. Almirall, S.A Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Almirall, S.A Semi-Solid Dosage Form Product
Table 153. Almirall, S.A Recent Developments/Updates
Table 154. Aclaris Therapeutics, Inc. Corporation Information
Table 155. Aclaris Therapeutics, Inc. Description and Business Overview
Table 156. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product
Table 158. Aclaris Therapeutics, Inc. Recent Developments/Updates
Table 159. Taro Pharmaceutical Industries Ltd. Corporation Information
Table 160. Taro Pharmaceutical Industries Ltd. Description and Business Overview
Table 161. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product
Table 163. Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 164. Teligent Pharma Corporation Information
Table 165. Teligent Pharma Description and Business Overview
Table 166. Teligent Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. Teligent Pharma Semi-Solid Dosage Form Product
Table 168. Teligent Pharma Recent Developments/Updates
Table 169. Perrigo Pharma Corporation Information
Table 170. Perrigo Pharma Description and Business Overview
Table 171. Perrigo Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 172. Perrigo Pharma Semi-Solid Dosage Form Product
Table 173. Perrigo Pharma Recent Developments/Updates
Table 174. Production Base and Market Concentration Rate of Raw Material
Table 175. Key Suppliers of Raw Materials
Table 176. Semi-Solid Dosage Form Distributors List
Table 177. Semi-Solid Dosage Form Customers List
Table 178. Semi-Solid Dosage Form Market Trends
Table 179. Semi-Solid Dosage Form Market Drivers
Table 180. Semi-Solid Dosage Form Market Challenges
Table 181. Semi-Solid Dosage Form Market Restraints
Table 182. Global Semi-Solid Dosage Form Sales Forecast by Type (2023-2028) & (K Units)
Table 183. Global Semi-Solid Dosage Form Sales Market Share Forecast by Type (2023-2028)
Table 184. Global Semi-Solid Dosage Form Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 185. Global Semi-Solid Dosage Form Revenue Market Share Forecast by Type (2023-2028)
Table 186. Global Semi-Solid Dosage Form Sales Forecast by Application (2023-2028) & (K Units)
Table 187. Global Semi-Solid Dosage Form Sales Market Share Forecast by Application (2023-2028)
Table 188. Global Semi-Solid Dosage Form Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 189. Global Semi-Solid Dosage Form Revenue Market Share Forecast by Application (2023-2028)
Table 190. Global Semi-Solid Dosage Form Sales Forecast by Region (2023-2028) & (K Units)
Table 191. Global Semi-Solid Dosage Form Sales Market Share Forecast by Region (2023-2028)
Table 192. Global Semi-Solid Dosage Form Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 193. Global Semi-Solid Dosage Form Revenue Market Share Forecast by Region (2023-2028)
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Semi-Solid Dosage Form
Figure 2. Global Semi-Solid Dosage Form Market Share by Type in 2021 & 2028
Figure 3. Ointments Product Picture
Figure 4. Gels Product Picture
Figure 5. Others Product Picture
Figure 6. Global Semi-Solid Dosage Form Market Share by Application in 2021 & 2028
Figure 7. Skin
Figure 8. Nasal Cavity
Figure 9. Vaginal Cavity
Figure 10. Rectal Cavity
Figure 11. Others
Figure 12. Global Semi-Solid Dosage Form Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Semi-Solid Dosage Form Market Size (2017-2028) & (US$ Million)
Figure 14. Global Semi-Solid Dosage Form Sales (2017-2028) & (K Units)
Figure 15. Semi-Solid Dosage Form Sales Share by Manufacturers in 2021
Figure 16. Global Semi-Solid Dosage Form Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Semi-Solid Dosage Form Players: Market Share by Revenue in 2021
Figure 18. Semi-Solid Dosage Form Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Semi-Solid Dosage Form Sales Market Share by Region (2017-2022)
Figure 20. Global Semi-Solid Dosage Form Sales Market Share by Region in 2021
Figure 21. Global Semi-Solid Dosage Form Revenue Market Share by Region (2017-2022)
Figure 22. Global Semi-Solid Dosage Form Revenue Market Share by Region in 2021
Figure 23. U.S. Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. UAE Semi-Solid Dosage Form Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Semi-Solid Dosage Form by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Semi-Solid Dosage Form
Figure 49. Manufacturing Process Analysis of Semi-Solid Dosage Form
Figure 50. Semi-Solid Dosage Form Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
